Biography

Alemnew Dagnew is the Clinical Development Leader for the M72 tuberculosis vaccine program at Gates MRI. He holds an M.D. and an M.Sc. from Addis Ababa University, an M.Sc. in Vaccinology from the University of Siena, and an MPH from Johns Hopkins. He has over 20 years of experience, including more than a decade at Novartis and GSK, where he worked on the clinical development of vaccines for typhoid, influenza, meningococcal disease, and shingles. For the past five years, he has led the M72 clinical program at Gates MRI, bringing global expertise to advance vaccine development and improve public health.